Product
Newborn Screening
Early discovery and intervention to keep children healthy
Sensorineural Hearing Loss Screening
In collaboration with Dr. Ko Tsang-Ming’s lab, Phalanx Biotech developed a test covering more than 90% of the four common hearing impairment-related genes and 361 alleles. It is used with conventional physical examination to provide parents with a more complete result.
Congenital Cytomegalovirus(CMV) Infection Screening
Cytomegalovirus infection causes congenital erroneous development of central nervous system. Conducting the test in two weeks following birth better excludes an acquired cytomegalovirus infection.
Congenital Central Hypoventilation Syndrome(CCHS) Screening
Congenital Central Hypoventilation Syndrome(CCHS) is an Autosomal dominant hereditary disorder associated with respiratory center. Its incidence is approximately 1/10,000~1/200,000. Early diagnosis in newborns via gene testing provides adequate respiratory support and treatment to reduce sudden death at night and improve survival.
With innovation and quality as its guiding values, Phalanx Biotech offers a wide array of genetic testing services.
If you have any questions about our products, please feel free to contact us!
Get in touch with us via email at service@phalanxbiotech.com or by phone at +886-3-578-1168 or +886-800-777988.